Credit Suisse Ag Concert Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $191,207 - $265,745	-20,255 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$12.07 - $17.54 $9,052 - $13,155	750 Added 3.85%	20,255 $244,000
Q4 2018 Feb 13, 2019	BUY	$11.25 - $16.17 $11,115 - $15,975	988 Added 5.34%	19,505 $244,000
Q3 2018 Nov 13, 2018	SELL	$12.82 - $17.88 $52,882 - $73,755	-4,125 Reduced 18.22%	18,517 $274,000
Q2 2018 Aug 14, 2018	SELL	$16.83 - $21.66 $1,497 - $1,927	-89 Reduced 0.39%	22,642 $381,000
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $13,198 - $19,228	-686 Reduced 2.93%	22,731 $520,000
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $135,774 - $282,540	9,726 Added 71.04%	23,417 $605,000
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $190,441 - $209,609	13,691	13,691 $202,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.